Trending Investment Opportunities
Advertisement
Gainers
- Indaptus Therapeutics INDP shares moved upwards by 211.66% to $22.04 during Wednesday's regular session. The market value of their outstanding shares is at $119.1 million.
- Allied Healthcare Prods AHPI stock rose 21.47% to $7.75. As of 12:30 EST, Allied Healthcare Prods's stock is trading at a volume of 1.5 million, which is 16.89% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $31.1 million.
- Seres Therapeutics MCRB stock increased by 14.28% to $6.24. The current volume of 4.4 million shares is 241.35% of Seres Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $572.3 million.
- Sonnet BioTherapeutics SONN shares rose 14.21% to $0.65. Sonnet BioTherapeutics's stock is trading at a volume of 47.9 million shares as of 12:30 EST. This is 580.29% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $37.5 million.
- Cyclacel Pharmaceuticals CYCC shares increased by 13.42% to $6.0. The current volume of 246.9K shares is 283.54% of Cyclacel Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $55.4 million.
- Immuneering IMRX shares moved upwards by 12.44% to $29.09. The market value of their outstanding shares is at $754.5 million. As per the news, the Q2 earnings report came out 4 days ago.
Losers
- Nuwellis NUWE stock declined by 27.38% to $2.68 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 933.9K shares, making up 427.49% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.5 million.
- Forte Biosciences FBRX stock fell 11.66% to $3.41. Trading volume for Forte Biosciences's stock is 3.7 million as of 12:30 EST. This is 220.13% of its average full-day volume over the last 100 days. The company's market cap stands at $48.0 million.
- Theravance Biopharma TBPH stock declined by 11.2% to $7.14. Trading volume for this security as of 12:30 EST is 9.2 million, which is 1021.02% of its average full-day volume over the last 100 days. The company's market cap stands at $524.5 million.
- Renalytix RNLX stock declined by 10.81% to $18.0. Trading volume for this security as of 12:30 EST is 169.6K, which is 179.93% of its average full-day volume over the last 100 days. The company's market cap stands at $650.0 million.
- ImmuCell ICCC stock decreased by 10.04% to $8.97. The market value of their outstanding shares is at $69.4 million.
- Sera Prognostics SERA stock declined by 9.6% to $8.86. The company's market cap stands at $259.5 million.
CYCCCyclacel Pharmaceuticals Inc
$8.02-35.0%
Edge Rankings
Momentum
0.77
Growth
N/A
Quality
N/A
Value
1.33
Price Trend
Short
Medium
Long
FBRXForte Biosciences Inc
$9.45-%
ICCCImmuCell Corp
$6.879.74%
IMRXImmuneering Corp
$3.90-6.70%
INDPIndaptus Therapeutics Inc
$13.399.84%
MCRBSeres Therapeutics Inc
$15.535.87%
NUWENuwellis Inc
$15.16119.9%
SERASera Prognostics Inc
$3.0613.3%
SONNSonnet BioTherapeutics Holdings Inc
$8.51-12.9%
TBPHTheravance Biopharma Inc
$11.630.87%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.